Yahoo
NasdaqCM - Delayed Quote USD

Vicore Pharma Holding AB (publ) (VCRE)

10.40 +0.39 (+3.90%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in SEK All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,994
3,817
109,346
0
0
Gross Profit
3,994
3,817
109,346
0
0
Operating Expense
529,671
458,262
299,706
320,889
287,494
Operating Income
-525,677
-454,445
-190,360
-320,889
-287,494
Net Non Operating Interest Income Expense
70,757
23,828
21,073
10,536
905
Pretax Income
-501,777
-477,474
-168,890
-311,326
-288,806
Tax Provision
259
0
-256
-384
-384
Net Income Common Stockholders
-502,036
-477,474
-168,634
-310,942
-288,422
Diluted NI Available to Com Stockholders
-502,036
-477,474
-168,634
-310,942
-288,422
Basic EPS
-19.10
-19.90
-12.30
-31.80
-38.82
Diluted EPS
-19.10
-19.90
-12.30
-31.80
-38.82
Basic Average Shares
26,335.65
23,988.33
13,684.45
9,655.88
7,422.04
Diluted Average Shares
26,335.65
23,988.33
13,684.45
9,655.88
7,422.04
Total Operating Income as Reported
-523,618
-452,386
-194,189
-321,506
-290,725
Total Expenses
529,671
458,262
299,706
320,889
287,494
Net Income from Continuing & Discontinued Operation
-502,036
-477,474
-168,634
-310,942
-288,422
Normalized Income
-502,036
-477,474
-168,634
-310,586
-287,954
Interest Income
29,920
23,888
21,081
10,538
913
Interest Expense
-40,837
60
8
2
8
Net Interest Income
70,757
23,828
21,073
10,536
905
EBIT
-542,614
-477,414
-168,882
-311,324
-288,798
EBITDA
-542,614
-477,414
-166,639
-307,901
-285,186
Reconciled Depreciation
--
0
2,243
3,423
3,612
Net Income from Continuing Operation Net Minority Interest
-502,036
-477,474
-168,634
-310,942
-288,422
Total Unusual Items Excluding Goodwill
0
-48,916
0
-356
-468
Total Unusual Items
0
-48,916
0
-356
-468
Normalized EBITDA
-542,614
-477,414
-166,639
-307,545
-284,718
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/6/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: